🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We're excited to announce our presentations at the upcoming ASGCT Annual Meeting, including an oral session on compelling preclinical data from Life Edit’s gene editing candidate, LETI-101, for Huntington's disease. Learn more: elevate.bio/press-releases…

We’ll be presenting at the ISCT! See Jeff Cram’s presentation "Evaluating Buoyancy Activated Cell Sorting (BACS) for T cell Isolation in CAR-T Manufacturing." Our team will also be at booth #524. For additional details, visit: isctglobal.org #ISCT2025

At ElevateBio, we recognize that working together as a team is vital for our success. This #MentalHealthAwarenessMonth, we are reminded of the importance of supporting our team by promoting healthy work life balance.

We are powering the industry with an integrated manufacturing & technology stack. We provide our partners the tools, facilities, & knowledge needed to develop genetic medicines faster & more efficiently, accelerating their delivery to patients worldwide: elevate.bio/partnering/

We partnered with Beam Therapeutics to manufacture BEAM-101, an investigational base editing therapy for sickle cell disease. BaseCamp's comprehensive strategy combined technical expertise with dedicated program management. Read our innovative approach here: elevate.bio/elevated-insig…

ElevateBio has appointed Ger Brophy as Interim CEO and member of its Board of Directors. Ger has served as a strategic advisor to our leadership team over the past year and is committed to strengthening our leadership in genetic medicines. Learn more: elevate.bio/press-releases…

We're looking forward to seeing you at #ASGCT2025! Stop by booth #509 and meet our team. Get all the details on our oral and poster presentations here: lnkd.in/emrsTiiP

ElevateBio BaseCamp’s comprehensive analytical development services provide insights into product quality and safety, right from the start. Our quality control methods & analytics help our partners accelerate timelines, saving costs: elevate.bio/end-to-end-cap…

We’re propelling CRISPR engineering & discovery efforts at an unprecedented pace to enable the development of genetic therapeutics for conditions once deemed untreatable. Learn how we’re leveraging #AI: elevate.bio/technology-pla…

BaseCamp’s viral vector & cell therapy manufacturing platforms tap into the technology, regulatory and scale-up expertise required for genetic medicine development. Explore our full spectrum of cGMP solutions: elevate.bio/end-to-end-cap…

Today we reflect and extend our gratitude to the men and women who have given their lives in service of our nation. Wishing everyone a safe Memorial Day weekend!

At Life Edit we offer a full spectrum of gene editing modalities for targeting genetic disorders. Learn more about how we offer unprecedented flexibility in three types of #GeneEditing: elevate.bio/technology-pla…

We’re enabling industry partners with our next-generation sequencing (NGS) services. Learn more in a recent Elevated Insight: bit.ly/4cXOmzD

We’re presenting at the CASSS - Sharing Science Solutions CGTP Summit! Join Will Arnold, Principal Scientist, Bioinformatics and Michael Giffin, Director, Analytical Development for the following presentations. Look forward to seeing you there!

ElevateBio BaseCamp's team is equipped to accelerate your genetic medicines development. Our extensive technical expertise, cutting-edge bioprocessing instruments, & deep understanding of your development needs ensure seamless program transition: elevate.bio/end-to-end-cap…

ElevateBio’s integrated model, combining gene editing and cGMP manufacturing, unifies groundbreaking technologies, forging the missing link between discovery and delivery. Learn more about our integrated ecosystem: elevate.bio/about/our-ecos…

We're honored to be recognized as a CNBC #Disruptor50 for the third year in a row! With our technology stack and manufacturing expertise, we are changing how genetic medicines are developed, designed, and delivered to patients. Read our profile here: cnbc.com/2025/06/10/ele…

We're headed to Biotechnology Innovation Organization 2025! Join Ger Brophy & Mike Paglia for the following panel discussions. Let's connect there! #BIO2025

ElevateBio BaseCamp’s purpose-built, multi-product facilities are engineered to support a variety of advanced therapies. Our clinical & commercial manufacturing processes are designed to accelerate your genetic medicines development at any stage. Visit: elevate.bio/end-to-end-cap…

Base editing converts one nucleotide (base) into another, without cutting both strands of DNA. Learn how our @LifeEdittx's PAM diversity enables base editing at more sites than any one nuclease could access: elevate.bio/technology-pla…